EAGLE-2 and EAGLE-3 phase III trials for gepotidacin stopped early for efficacy following pre-planned interim analysis by Independent Data Monitoring Committee
The Pharma Data
NOVEMBER 3, 2022
Sat.Oct 29, 2022 - Fri.Nov 04, 2022
83 
Building a biotech in a downturn: 3 lessons from VCs and startup CEOs
Bio Pharma Dive
NOVEMBER 3, 2022
In a panel discussion hosted by BioPharma Dive, venture capitalists and CEOs discussed how startups can navigate a challenging market as well as possible ripple effects from the new U.S. drug pricing law
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
GSK speeds up the race to bring first RSV vaccine for older adults to market
Pharmaceutical Technology
OCTOBER 31, 2022
After decades of setbacks, the respiratory syncytial virus (RSV) vaccine field has bounced back with positive Phase III trial results in older adults.
Terumo Pharmaceutical Solutions expands CDMO services outside Japan for global marketÂ
Pharma Mirror
NOVEMBER 4, 2022
Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has today announced it will expand its contract development and manufacturing services for parenteral drugs to global customers.
2022 Research: The Rapid Rise of Ocean Freight Visibility
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
AstraZeneca finances R&D Postdoctoral Challenge finalists
The Pharma Data
NOVEMBER 3, 2022
AstraZeneca finances R&D Postdoctoral Challenge finalists Six finalists awarded completely funded postdoctoral exploration positions.
Bispecific cancer drugs and gene therapy advances: What to watch at next month’s ASH meeting
Bio Pharma Dive
NOVEMBER 4, 2022
Competition is increasing behind newly approved drugs from Roche and J&J, while the long-term benefit of gene therapies for chronic blood disorders is being put to the test
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Digital cognitive behaviour therapies recommended by NICE across the NHS
Pharma Times
NOVEMBER 4, 2022
Treatment will assist young people and children with symptoms of mild-to-moderate anxiety
U.S. FDA Approves Vemlidy® (tenofovir alafenamide) for Treatment of Chronic Hepatitis B Virus Infection in Pediatric Patients
The Pharma Data
NOVEMBER 3, 2022
Blessing Expands on former FDA blessing of Vemlidy in Grown-ups Living With This habitual Liver complaint –. efficacity and Safety of formerly-diurnal Vemlidy Demonstrated in individualities 12 Times of Age and Aged – FOSTER CITY,Calif.–( –( BUSINESS WIRE)– Gilead lores,Inc.(
String of gene therapy deals spurs cautious optimism on Wall Street
Bio Pharma Dive
NOVEMBER 1, 2022
To some analysts, the recent acquisitions of Akouos and AGTC, as well as Astellas’ equity investment in Taysha, are a positive signal for an area of drug research that’s been “in investors' penalty box for much of 2022 &rdquo
Inside the European mass shift to data-driven health solutions
Pharmaceutical Technology
NOVEMBER 1, 2022
In a few weeks, the EU-funded research project Darwin EU will announce its first batch of data partners for the ambitious real-world data -driven Horizon 2020 project.
An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Moderna can't hide behind the government in patent infringement suit, judge rules
Fierce Pharma
NOVEMBER 3, 2022
Moderna can't hide behind the government in patent infringement suit, judge rules. zbecker. Thu, 11/03/2022 - 15:47
The origin- of- life patch, a key to cancer exploration
The Pharma Data
OCTOBER 31, 2022
The origin- of- life patch, a key to cancer exploration. RNA, the patch that gave rise to life, has been shown to be essential for repairing mortal inheritable material and precluding mutations that might lead to developing cancer.
Artiva cancels IPO plans and cuts a deal with Affimed
Bio Pharma Dive
NOVEMBER 3, 2022
With public offerings difficult to pull off, Artiva is focusing its energy on a cancer drug deal with the German biotech
Recurrent drug shortages signal onerous outlook for cardiovascular care
Pharmaceutical Technology
NOVEMBER 3, 2022
Drug shortages continue affecting cardiovascular clinical practice across the world, reflecting rising demand and cost-effective manufacturing challenges.
Mandatory COVID Vaccination Policy Template
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
New device launched for diagnosing prostate cancer
Pharma Times
NOVEMBER 1, 2022
CamPROBE may save vital time and money while reducing the risk of infection
Allergan Aesthetics Celebrates Fourth Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day
The Pharma Data
NOVEMBER 3, 2022
Allergan Aesthetics Celebrates Fourth Annual BOTOX ® Cosmetic( onabotulinumtoxinA) Day Allergan Aesthetics, an AbbVie company( NYSE ABBV), is inviting people across the country to take a” Moment for You” on Wednesday, November 16 and celebrate the biggest event of the time for BOTOX ® Cosmetic.
What the FDA’s guidance on diversity means for rare disease sponsors
Bio Pharma Dive
OCTOBER 31, 2022
Bringing more diversity to clinical trials is a slow process and it takes time to get right. Learn how Worldwide Clinical Trials can diversify the reach of your orphan drug trial
Roche’s Actemra gets Health Canada approval for Covid-19 treatment
Pharmaceutical Technology
OCTOBER 31, 2022
Hoffmann-La Roche (Roche Canada) has received approval from Health Canada for Actemra IV (tocilizumab for injection) vials to treat Covid-19 patients.
Aelix and Gilead announce results of HIV infection candidate
Pharma Times
NOVEMBER 2, 2022
The study evaluated the safety, efficacy and immunogenicity of AELIX’s HIV vaccine
Pfizer Announces Positive Top- Line Data of Phase 3 Global motherly Immunization Trial for its Bivalent Respiratory Syncytial Virus( RSV) Vaccine seeker
The Pharma Data
NOVEMBER 1, 2022
Pfizer Announces Positive Top- Line Data of Phase 3 Global motherly Immunization Trial for its Bivalent Respiratory Syncytial Virus( RSV) Vaccine seeker. Vaccine efficacity of81.8
FDA again delays review of Amicus rare disease drug
Bio Pharma Dive
OCTOBER 31, 2022
For the second time this year, the agency has put off a decision on Amicus' therapy for Pompe disease. European regulators are also reviewing the treatment and could soon issue an opinion
MIT and Toyota Improve Robotic Grasping Techniques
Pharmaceutical Technology
OCTOBER 30, 2022
Concept: Massachusetts Institute of Technology (MIT)’s Computer Science and Artificial Intelligence Laboratory (CSAIL) researchers have developed a system called ‘series elastic end effectors’ (SEED) that enable robots to use grabbed tools correctly and successfully.
New evidence review uncovers ‘significant’ link between particulate matter and dementia
Pharma Times
OCTOBER 31, 2022
Information from 17 existing studies was reviewed, involving 91 million people
Vaxzevria receives full Marketing Authorisation in the EU for the forestallment of COVID- 19
The Pharma Data
NOVEMBER 1, 2022
Moderna cuts sales forecasts for its COVID-19 vaccine
Bio Pharma Dive
NOVEMBER 3, 2022
The biotech dialed back its financial projections after reporting lower-than-expected sales for the shot, which currently remains the company’s only marketed product
What can Rishi Sunak do for the UK’s pharma industry
Pharmaceutical Technology
NOVEMBER 4, 2022
Last week, after a tumultuous 45 days under Liz Truss’s control , the role of the UK’s Prime Minister (PM) was passed on to Rishi Sunak , in a bid to restore balance to the British economy. During her short reign, Truss’s cabinet had promised a £45 billion ($51.59
Could digital therapeutics provide a solution against opioid abuse?
Pharma Phorum
NOVEMBER 2, 2022
Digital therapeutics are rapidly coming into the foreground to treat a variety of conditions. Ben Hargreaves discovers how chronic pain could be a key area for digital therapeutics, as they offer non-addictive and effective relief from the condition.
Bristol Myers Squibb Announces Positive Topline Results of Phase 3 COMMANDS Trial
The Pharma Data
OCTOBER 31, 2022
Bristol Myers Squibb Announces Positive Topline Results of Phase 3 COMMANDS Trial. eblozyl, the first erythroid development agent, met primary and crucial secondary endpoints in the first- line treatment of cases with veritably low low/ intermediate- threat myelodysplastic runs PRINCETON,N.J.–(
Novo obesity drug sales lag as manufacturing problems persist
Bio Pharma Dive
NOVEMBER 2, 2022
Manufacturing problems continue to weigh on Novo’s Wegovy launch as competition looms from Eli Lilly’s fast-selling diabetes medicine Mounjaro
Rankings: Research and Development
Pharmaceutical Technology
NOVEMBER 1, 2022
FEATURED COMPANIES COMMENDED : • Innovation • Product Launch • Safety VIEW PROFILE COMMENDED : • Business Expansion • Innovation • Investments VIEW PROFILE COMMENDED: • Social VIEW PROFILE. The Excellence Rankings celebrate the greatest achievements and innovations in the industry.
Verge Genomics takes AI-sourced drug for ALS into clinic
Pharma Phorum
OCTOBER 31, 2022
Verge Genomics has joined a select group of biotechs who have taken a drug discovered and developed using artificial intelligence into human testing.
New Perceptivity on antibody responses to Omicron variants
The Pharma Data
OCTOBER 31, 2022
New Perceptivity on antibody responses to Omicron variants Knowing how well vaccination against one SARS- CoV- 2 strain( with or without former infection) counteracts infection with a different strain is a critical exploration question.
Lilly sales of new diabetes drug accelerate on rising patient demand
Bio Pharma Dive
NOVEMBER 1, 2022
Company executives highlighted the “viral nature” of demand for Mounjaro, which was approved in May for diabetes and has also shown a strong weight-loss benefit in clinical testing
EMA grants full marketing authorisation for AstraZeneca’s Covid-19 vaccine
Pharmaceutical Technology
NOVEMBER 2, 2022
The European Medicines Agency (EMA) has granted full marketing authorisation (MA) for AstraZeneca ’s Covid-19 vaccine, Vaxzevria (ChAdOx1-S [Recombinant]). The vaccine initially received a conditional marketing authorisation (cMA) for use in the European Union (EU).
Let's personalize your content